HEALTH AND MEDICINE (TechNewsWorld.com)
After about two years, 6.2 percent of those on BiDil had died, compared with 10.2 percent on those on placebo. Also during that period, 16.4 percent on BiDil were hospitalized for heart failure, compared with 24.4 percent of the rest.

